Abstract:Methylenetetrahydrofolate reductase (MTHFR) gene plays key roles not only in folate metabolism but also in carcinogenesis. The single nucleotide polymorphism MTHFR C677T has been indicated in the development of various tumors. The effect of the MTHFR C677T polymorphism on brain tumors remains poorly understood. We performed the present meta-analysis and aimed to provide a better understanding of the pathogenesis of brain tumors. A literature search of the PubMed, Embase, Web of Science, and Wanfang databases was carried out for potential relevant publications. We calculated the pooled odds ratio (OR) with corresponding 95% confidence interval (95% CI) to assess the association of MTHFR C677T with the susceptibility to brain tumors. We also performed stratified analysis and sensitivity analysis to further estimate the genetic association. All statistical analyses were conducted by the use of STATA 11.0 (STATA Corporation, College Station, TX, USA). Eight case-control studies involving a total of 3,059 cases and 3,324 controls were retrieved according to the inclusion criteria. The overall ORs suggested that the MTHFR C677T variant can exert a risk effect on brain tumor development under the following contrast models (OR(TC vs. CC) = 1.14, 95% CI 1.02-1.27, P OR = 0.018; OR(TT + TC vs. CC)= 1.23, 95% CI 1.01-1.51, P(OR) = 0.043). No significant correlation was identified among the Caucasians, but not among the Asians. In addition, the TC genotype carriers were more susceptible to meningioma when compared with the CC genotype carriers (OR(TC vs. CC) = 1.38, 95% CI 1.15-1.65, P(OR) < 0.001). The MTHFR C677T polymorphism seemed to exert no effect on glioma risk. The current meta-analysis firstly provides evidence that the MTHFR C677T polymorphism may modify the risk for brain tumors, particularly meningioma. The role of the MTHFR C677T variant in brain tumor pathogenesis across diverse ethnicities needs further elucidation by more future studies with large sample size.

5,10-Methylenetetrahydrofolate reductase ( MTHFR ), methionine synthase ( MTRR ), and methionine synthase reductase ( MTR ) gene polymorphisms and adult meningioma risk

Association Between the MTHFR A1298C Polymorphism and Risk of Cancer: Evidence from 265 Case–control Studies

Diets, polymorphisms of methylenetetrahydrofolate reductase, and the susceptibility of colon cancer and rectal cancer.

FOLIC ACID,METHIONINE,AND POLYMORPHISMS OF METHYLENETETRAHYDROFOLATE REDUCTASES AND SUSCEPTIBILITY OF COLORECTAL CANCER

Meta-analysis on the Relationship Between MTHFR Gene Polymorphisms and Colorectal Cancer

Role of Methylenetetrahydrofolate Reductase 677C→T Polymorphism in the Development of Myocardial Infarction: Evidence from an Original Study and Updated Meta-Analysis

Association of methionine synthase rs1801394 and methionine synthase reductase rs1805087 polymorphisms with meningioma in adults: A meta-analysis.

Polymorphisms of 5,10-methylenetetrahydrofolate reductase and thymidylate synthase, dietary folate intake, and the risk of leukemia in adults

The Methylenetetrahydrofolate Reductase ( MTHFR ) C677T Polymorphism and Tumor Risk: Evidence from 134 Case–control Studies

Association of the MTHFR C677T Polymorphism with Primary Brain Tumor Risk.

Association between MTHFR 677C>T polymorphism and risk of gliomas: evidence from a meta-analysis

The Relationship Between Methylenetetrahydrofolate Reductase Polymorphism and Hematological Malignancy.

The Polymorphisms in Methylenetetrahydrofolate Reductase, Methionine Synthase, Methionine Synthase Reductase, and the Risk of Colorectal Cancer

[Single Nucleotide Polymorphisms in Methylenetetrahydrofolate Reductase Gene and Susceptibility to Cancer of the Gastric Cardia in Chinese Population].

[Association Between Genetic Polymorphisms in Methylentetrahydrofolate Reductase and Risk of Lung Cancer].

Association Between MTHFR Gene Polymorphisms (C677T, A1298C) and Genetic Susceptibility to Prostate Cancer: a Meta-Analysis

MTHFR C677T and A1298C polymorphisms and risk of lung cancer: a comprehensive evaluation.

The MTHFR C677T Polymorphism and Risk of Intracerebral Hemorrhage in a Chinese Han Population.

MTHFR C677T and A1298C polymorphisms and cervical carcinoma susceptibility: meta-analyses based on 4421 individuals

Methylenetetrahydrofolate Reductase Polymorphisms and Breast Cancer Risk: a Meta-Analysis from 41 Studies with 16,480 Cases and 22,388 Controls

Different roles of MTHFR C677T and A1298C polymorphisms in colorectal adenoma and colorectal cancer: a meta-analysis